224 related articles for article (PubMed ID: 30062347)
1. Intracellular delivery and biodistribution study of CRISPR/Cas9 ribonucleoprotein loaded bioreducible lipidoid nanoparticles.
Li Y; Bolinger J; Yu Y; Glass Z; Shi N; Yang L; Wang M; Xu Q
Biomater Sci; 2019 Jan; 7(2):596-606. PubMed ID: 30062347
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial library of chalcogen-containing lipidoids for intracellular delivery of genome-editing proteins.
Li Y; Yang T; Yu Y; Shi N; Yang L; Glass Z; Bolinger J; Finkel IJ; Li W; Xu Q
Biomaterials; 2018 Sep; 178():652-662. PubMed ID: 29549971
[TBL] [Abstract][Full Text] [Related]
3. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
[TBL] [Abstract][Full Text] [Related]
4. Poly-sgRNA/siRNA ribonucleoprotein nanoparticles for targeted gene disruption.
Ha JS; Lee JS; Jeong J; Kim H; Byun J; Kim SA; Lee HJ; Chung HS; Lee JB; Ahn DR
J Control Release; 2017 Mar; 250():27-35. PubMed ID: 28167287
[TBL] [Abstract][Full Text] [Related]
5. Integrating Combinatorial Lipid Nanoparticle and Chemically Modified Protein for Intracellular Delivery and Genome Editing.
Chang J; Chen X; Glass Z; Gao F; Mao L; Wang M; Xu Q
Acc Chem Res; 2019 Mar; 52(3):665-675. PubMed ID: 30586281
[TBL] [Abstract][Full Text] [Related]
6. Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles.
Wang M; Zuris JA; Meng F; Rees H; Sun S; Deng P; Han Y; Gao X; Pouli D; Wu Q; Georgakoudi I; Liu DR; Xu Q
Proc Natl Acad Sci U S A; 2016 Mar; 113(11):2868-73. PubMed ID: 26929348
[TBL] [Abstract][Full Text] [Related]
7. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
Li S; Song Z; Liu C; Chen XL; Han H
ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
[TBL] [Abstract][Full Text] [Related]
8. Delivery of Cas9/sgRNA Ribonucleoprotein Complexes via Hydroxystearyl Oligoamino Amides.
Kuhn J; Lin Y; Krhac Levacic A; Al Danaf N; Peng L; Höhn M; Lamb DC; Wagner E; Lächelt U
Bioconjug Chem; 2020 Mar; 31(3):729-742. PubMed ID: 31967454
[TBL] [Abstract][Full Text] [Related]
9. Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing.
Wei T; Cheng Q; Min YL; Olson EN; Siegwart DJ
Nat Commun; 2020 Jun; 11(1):3232. PubMed ID: 32591530
[TBL] [Abstract][Full Text] [Related]
10. Intracellular Delivery of His-Tagged Genome-Editing Proteins Enabled by Nitrilotriacetic Acid-Containing Lipidoid Nanoparticles.
Li Y; Li AC; Xu Q
Adv Healthc Mater; 2019 Mar; 8(6):e1800996. PubMed ID: 30565897
[TBL] [Abstract][Full Text] [Related]
11. Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing.
Lyu P; Javidi-Parsijani P; Atala A; Lu B
Nucleic Acids Res; 2019 Sep; 47(17):e99. PubMed ID: 31299082
[TBL] [Abstract][Full Text] [Related]
12. Enhanced intracellular siRNA delivery using bioreducible lipid-like nanoparticles.
Wang M; Alberti K; Varone A; Pouli D; Georgakoudi I; Xu Q
Adv Healthc Mater; 2014 Sep; 3(9):1398-403. PubMed ID: 24574196
[TBL] [Abstract][Full Text] [Related]
13. Rationally designed nanoparticle delivery of Cas9 ribonucleoprotein for effective gene editing.
Chae SY; Jeong E; Kang S; Yim Y; Kim JS; Min DH
J Control Release; 2022 May; 345():108-119. PubMed ID: 35247491
[TBL] [Abstract][Full Text] [Related]
14. Delivery of the Cas9/sgRNA Ribonucleoprotein Complex in Immortalized and Primary Cells via Virus-like Particles ("Nanoblades").
Mangeot PE; Guiguettaz L; Sohier TJM; Ricci EP
J Vis Exp; 2021 Mar; (169):. PubMed ID: 33871447
[TBL] [Abstract][Full Text] [Related]
15. LNP-mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea.
Mirjalili Mohanna SZ; Djaksigulova D; Hill AM; Wagner PK; Simpson EM; Leavitt BR
J Control Release; 2022 Oct; 350():401-413. PubMed ID: 36029893
[TBL] [Abstract][Full Text] [Related]
16. Near-Infrared Light Activated Formulation for the Spatially Controlled Release of CRISPR-Cas9 Ribonucleoprotein for Brain Gene Editing.
Simões S; Lino M; Barrera A; Rebelo C; Tomatis F; Vilaça A; Breunig C; Neuner A; Peça J; González R; Carvalho A; Stricker S; Ferreira L
Angew Chem Int Ed Engl; 2024 May; 63(21):e202401004. PubMed ID: 38497898
[TBL] [Abstract][Full Text] [Related]
17. Finely tuned ionizable lipid nanoparticles for CRISPR/Cas9 ribonucleoprotein delivery and gene editing.
Im SH; Jang M; Park JH; Chung HJ
J Nanobiotechnology; 2024 Apr; 22(1):175. PubMed ID: 38609947
[TBL] [Abstract][Full Text] [Related]
18. Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo.
Bykonya AG; Lavrov AV; Smirnikhina SA
Mol Biotechnol; 2023 Feb; 65(2):181-195. PubMed ID: 35322386
[TBL] [Abstract][Full Text] [Related]
19. Genome Editing in a Wide Area of the Brain Using Dendrimer-Based Ternary Polyplexes of Cas9 Ribonucleoprotein.
Taharabaru T; Yokoyama R; Higashi T; Mohammed AFA; Inoue M; Maeda Y; Niidome T; Onodera R; Motoyama K
ACS Appl Mater Interfaces; 2020 May; 12(19):21386-21397. PubMed ID: 32315156
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Cytosolic Delivery and Release of CRISPR/Cas9 by Black Phosphorus Nanosheets for Genome Editing.
Zhou W; Cui H; Ying L; Yu XF
Angew Chem Int Ed Engl; 2018 Aug; 57(32):10268-10272. PubMed ID: 29939484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
